Detalhe da pesquisa
1.
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Hum Mutat
; 40(9): 1557-1578, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31131967
2.
CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients.
Tumour Biol
; 36(8): 5943-51, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25731731
3.
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing.
Genes (Basel)
; 15(2)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397209
4.
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers.
Front Oncol
; 11: 700853, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552867
5.
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review.
Front Oncol
; 9: 759, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456944
6.
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Clin Cancer Res
; 13(21): 6518-26, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17975165
7.
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Breast
; 16(3): 280-92, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17257844
8.
Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.
Tumori
; 103(1): 66-71, 2017 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26391764
9.
Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
Acta Biomed
; 87(1): 54-63, 2016 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27163896
10.
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.
Tumori
; 91(6): 505-12, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16457150
11.
Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report.
Tumori
; 100(1): e20-3, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24675505
12.
Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC).
Lung Cancer
; 83(2): 265-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24388705
13.
Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients.
Lung Cancer
; 86(3): 324-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453846
14.
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.
Cancer Chemother Pharmacol
; 73(2): 299-307, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24258456
15.
Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples.
Diagn Cytopathol
; 41(7): 595-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22833420
16.
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
Lung Cancer
; 80(1): 35-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352033
17.
EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.
Appl Immunohistochem Mol Morphol
; 20(4): 356-62, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22710815
18.
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
J Clin Oncol
; 26(11): 1789-96, 2008 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18347005
19.
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
J Thorac Oncol
; 3(10): 1104-11, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18827605
20.
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
Breast Cancer Res Treat
; 91(2): 203-5, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15868448